A virosome-mimotope approach to synthetic vaccine design and optimization: Synthesis, conformation, and immune recognition of a potential malaria-vaccine candidate

Angewandte Chemie - International Edition

Volumn 42, Issue 21, 2003, Pages 2368-2371

  Pfeiffer, Bernhard ^a   Peduzzi, Elisabetta ^b   Moehle, Kerstin ^a   Zurbriggen, Rinaldo ^c   Glück, Reinhard ^d   Pluschke, Gerd ^b   Robinson, John ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^c Pevion Biotech Ltd   (Switzerland)

^d Berna Biotech Ltd   (Switzerland)

Author keywords

Antibodies; Conformation analysis; Immunochemistry; Peptides; Peptidomimetics

Indexed keywords

ANTIBODIES; IMMUNIZATION; PROTEINS; SYNTHESIS (CHEMICAL);

IMMUNE SYSTEM;

VACCINES;

MALARIA VACCINE; VIROSOME;

ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; DRUG CONFORMATION; DRUG DESIGN; DRUG SYNTHESIS; IMMUNE SYSTEM; NONHUMAN; PLASMODIUM FALCIPARUM; SPOROZOITE; VIRUS PARTICLE;

ANIMALS; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALARIA VACCINES; MICE; MICE, INBRED BALB C; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MOLECULAR MIMICRY; PLASMODIUM FALCIPARUM;

EID: 0038343611     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/anie.200250348     Document Type: Article

References (20)

1. M. Tsuji, E. G. Rodrigues, R. S. Nussenzweig, Biol Chem, 2001, 382, 553.
2. Ciba Foundation Symposium 119: Synthetic Peptides as Antigens (Eds.: R. Porter, J. Whelan), Wiley, Chichester, UK, 1986.
3. R. Glück, Vaccine 1999, 17, 1782.
4. I. P. Hunziker, R. Zurbriggen, R. Glueck, O. B. Engler, J. Reichen, W. J. Dai, W. J. Pichler, A. Cerny, Mol. Immunol. 2001, 38, 475.
5. R. Zurbriggen, R. Glück, Vaccine 1999, 17, 1301.
6. D. A. Herrington, D. F. Clyde, G. Losonsky, M. Cortesia, J. R. Murphy, J. Davis, S. Baqar, A.M. Felix, E. P. Heimer, D. Gillessen, E. Nardin, R. S. Nussenzweig, V. Nussenzweig, M. R. Hollingdale, M. M. Levine, Nature 1987, 328, 257; for other examples, see reference [1].
7. F. Zavala, J. P. Tam, M. R. Hollingdale, A. H. Cochrane, I. Quakyi, R. S. Nussenzweig, V. Nussenzweig, Science 1985, 228, 1436.
8. J. B. Dame, J. L. Williams, T. F. McCutchan, J. L. Weber, R. A. Wirtz, W. T. Hockmeyer, W. L. Maloy, J. D. Haynes, I. Schneider, D. Roberts, G. S. Sanders, E. P. Reddy, C. L. Diggs, L. H. Miller, Science 1984, 225, 593.
9. R. Moreno, L. Jiang, K. Moehle, R. Zurbriggen, R. Glück, J. A. Robinson, G. Pluschke, ChemBioChem 2001, 2, 838.
10. H. J. Dyson, A. C. Satterthwait, R. A. Lerner, P. E. Wright, Biochemistry 1990, 29, 7828.
11. K. D. Gibson, H. A. Scheraga, Proc. Natl. Acad. Sci. USA 1986, 83, 5649.
12. I. K. Roterman, K. D. Gibson, H. A. Scheraga, J. Biomol. Struct. Dyn. 1989, 7, 391.
13. B. R. Brooks, R. W. Pastor, F. W. Carson, Proc. Natl. Acad. Sci. USA 1987, 84, 4470.
14. C. Bisang, C. Weber, J. Inglis, C. A. Schiffer, W. F. van Gunsteren, I. Jelesarov, H. R. Bosshard, J. A. Robinson, J. Am. Chem. Soc. 1995, 117, 7904.
15. C. Bisang, L. Jiang, E. Freund, F. Emery, C. Bauch, H. Matile, G. Pluschke, J. A. Robinson, J. Am. Chem. Soc. 1998, 120, 7439.
16. For the starting bicyclic lactam, see: P. Angehrn, R. L. Charnas, K. Gubernator, E.-M. Gutknecht, C. Hubschwerlen, M. Kania, C. Oefner, M. G. P. Page, S. Sogabe, J.-L. Specklin, F. Winkler, J. Med. Chem. 1998, 41, 3961-3971.
17. R. Glück, R. Mischler, B. Finkel, J. U. Que, B. Scarpa, S. J. Cryz, Lancet 1994, 344, 160.
18. F. Poltl-Frank, R. Zurbriggen, A. Helg, F. Stuart, J. A. Robinson, R. Glück, G. Pluschke, Clin. Exp. Immunol. 1999, 117, 496-503.
19. Full details of the immunological data will be published elsewhere.
20. R. Koradi, M. Billeter, K. Wüthrich, J. Mol. Graphics 1996, 14, 51-55.